| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/05/2015 | WO2015016698A1 Pharmaceutical composition with antiinflammatory agents and production process |
| 02/05/2015 | WO2015016697A1 Three-phase system for modified release of a non-steroidal antiinflammatory |
| 02/05/2015 | WO2015016696A1 Pharmaceutical composition for treating pain |
| 02/05/2015 | WO2015016695A1 Novel biphasic-delivery pharmaceutical system for the treatment of pain and inflammation |
| 02/05/2015 | WO2015016694A1 Stable solid immunosuppressor composition |
| 02/05/2015 | WO2015016682A1 Pharmaceutical composition for preventing or treating diabetes mellitus, method for preventing or treating diabetes mellitus, and method for screening for diabetes mellitus therapeutic agent |
| 02/05/2015 | WO2015016667A1 Orally disintegrating film preparation containing donepezil or pharmaceutically acceptable salt thereof, and preparation method therefor |
| 02/05/2015 | WO2015016511A1 Novel biphenyl derivative and method for preparing same |
| 02/05/2015 | WO2015016500A1 Composition for preventing skin aging containing aloesin or derivative thereof |
| 02/05/2015 | WO2015016428A1 Antiviral composition for fish containing quercetin as active ingredient |
| 02/05/2015 | WO2015016372A1 Tetrazolinone compound, and use therefor |
| 02/05/2015 | WO2015016335A1 Tetrazolinone compound and use thereof |
| 02/05/2015 | WO2015016295A1 Pharmaceutical preparation comprising aminopyrazole derivative |
| 02/05/2015 | WO2015016293A1 (benzenesulfonylamino)benzamide derivative, and ship2 inhibitor containing same as active ingredient |
| 02/05/2015 | WO2015016285A1 Brain function-improving composition |
| 02/05/2015 | WO2015016282A1 Pharmaceutical composition for preventing or treating radiation-induced gastrointestinal syndrome |
| 02/05/2015 | WO2015016256A1 Tablet |
| 02/05/2015 | WO2015016206A1 Heterocyclic compound |
| 02/05/2015 | WO2015016195A1 Wnt SIGNALING INHIBITOR |
| 02/05/2015 | WO2015016178A1 Function inhibitor of apoptosis-associated speck-like protein containing card comprising 1,5-d-anhydrofructose |
| 02/05/2015 | WO2015015989A1 Agent for alleviating side effects in cancer chemotherapy |
| 02/05/2015 | WO2015015818A1 Composition for ameliorating metabolic disorders caused by diabetes |
| 02/05/2015 | WO2015015816A1 Fibroblast activator |
| 02/05/2015 | WO2015015815A1 Fibroblast activator |
| 02/05/2015 | WO2015015654A1 Corneal endothelium ecm therapeutic drug |
| 02/05/2015 | WO2015015519A1 Novel indazole compounds and a process for the preparation thereof |
| 02/05/2015 | WO2015015509A2 Ulmoside-a: useful for prevention or cure of metabolic diseases |
| 02/05/2015 | WO2015015459A1 Transdermal administration system for use in the treatment of chronic bronchopulmonary diseases |
| 02/05/2015 | WO2015015446A1 Topical compositions for treatment of excessive sweating and methods of use thereof |
| 02/05/2015 | WO2015015420A1 Novel derivatives of a 3,4-dihydroisoquinoline-3-carboxylic acid having anti-cancer properties, a method for their synthesis, pharmaceutical compositions comprising said derivatives, and their use |
| 02/05/2015 | WO2015015407A1 Composition comprising hyaluronic acid and mepivacaine |
| 02/05/2015 | WO2015015254A1 Pharmaceutical compositions of fingolimod |
| 02/05/2015 | WO2015015248A1 The use of compounds showing heat shock protein (hsp) co-inducing properties to enhance the insulin sensitizing effect in the treatment of type 2 diabetes |
| 02/05/2015 | WO2015015240A1 New process to make non-nucleosidal reverse transcriptase inhibitors (nnrti) for the treatment of hiv |
| 02/05/2015 | WO2015015186A1 Characterization of rice |
| 02/05/2015 | WO2015015149A1 Dietary supplement |
| 02/05/2015 | WO2015015062A1 Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel |
| 02/05/2015 | WO2015015039A1 Boosting the effect of methotrexate through the combined use with lipophilic statins |
| 02/05/2015 | WO2015015013A1 Combinations of a btk inhibitor and fluorouracil for treating cancers |
| 02/05/2015 | WO2015014998A1 Pharmaceutical formulation containing thienotriazolodiazepine compounds |
| 02/05/2015 | WO2015014987A1 A modified-release oral pharmaceutical formulation containing gliclazide |
| 02/05/2015 | WO2015014980A1 Composition comprising tapentadol in a dissolved form |
| 02/05/2015 | WO2015014972A1 2-benzoylaminobenzamide derivatives as bcl-3 inhibitors |
| 02/05/2015 | WO2015014967A1 Glyceride composition |
| 02/05/2015 | WO2015014900A1 Di(hetero)arylamides and sulfonamides, methods for their preparation and therapeutic uses thereof |
| 02/05/2015 | WO2015014869A1 Tumor antigens for determining cancer therapy |
| 02/05/2015 | WO2015014851A1 Hydroxyalkyl starch for the treatment of hematological neoplasms |
| 02/05/2015 | WO2015014838A1 Neurocalcin delta inhibitors and therapeutic and non-therapeutic uses thereof |
| 02/05/2015 | WO2015014816A1 1,2-disubstituted cyclobutyl compounds |
| 02/05/2015 | WO2015014815A1 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS |
| 02/05/2015 | WO2015014785A1 Compounds for enhancing the cognitive function |
| 02/05/2015 | WO2015014768A1 1,7-naphthyridine derivatives |
| 02/05/2015 | WO2015014766A1 Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel |
| 02/05/2015 | WO2015014737A1 Multilayer tablet formulations comprising tenofovir and entecavir |
| 02/05/2015 | WO2015014730A1 Polysaccharide for use in preventing metastasis formation and/or relapse |
| 02/05/2015 | WO2015014666A1 Methods and pharmaceutical compositions for the treatment of ventilator-induced diaphragmatic dysfunction |
| 02/05/2015 | WO2015014634A1 Selective at2 receptor agonists for use in treatment of cachexia |
| 02/05/2015 | WO2015014492A1 New composition to treat inflammation |
| 02/05/2015 | WO2015014470A1 Compositions for ameliorating and/or preventing adverse side effects in antibiotic therapy |
| 02/05/2015 | WO2015014446A1 1,3-disubstituted cyclopentane derivatives |
| 02/05/2015 | WO2015014442A1 Oxoquinazolinyl-butanamide derivatives |
| 02/05/2015 | WO2015014375A1 Tumor antigens for determining cancer therapy |
| 02/05/2015 | WO2015014329A1 Pharmaceutical composition comprising monensin for treating of diseases associated with deregulated wnt signaling pathway |
| 02/05/2015 | WO2015014315A1 Inhibitor crystalline form and preparation method and use thereof |
| 02/05/2015 | WO2015014284A1 Method for treating breast cancer |
| 02/05/2015 | WO2015014283A1 Protein tyrosine kinase inhibitor and application thereof |
| 02/05/2015 | WO2015014261A1 Macrolide compound or salt thereof, synthesis method, pharmaceutical composition, and application thereof |
| 02/05/2015 | WO2015014256A1 Substituted heteroaryl compounds and methods of use thereof |
| 02/05/2015 | WO2015014230A1 Matrix metalloproteinase inhibitor and use thereof |
| 02/05/2015 | WO2015014209A1 Pyruvate pharmaceutical compositions for osmotic stability and detoxification effect thereof in healthy human beings and lung disease patients |
| 02/05/2015 | WO2015014089A1 Ticagrelor monohydrate, preparation method therefor and use thereof in pharmacy |
| 02/05/2015 | WO2015013903A1 NEW AGOMELATINE p-TOLUENESULFONIC ACID CO-CRYSTAL FORMS AND PREPARATION THEREOF |
| 02/05/2015 | WO2015013865A1 Agomelatine sulfonic acids complexes and preparation thereof |
| 02/05/2015 | WO2015013835A1 Piperazine derivatives as hiv protease inhibitors |
| 02/05/2015 | WO2015013821A1 Composition comprising polyglucosamine-glyoxylate solutions mixed with hyaluronan |
| 02/05/2015 | WO2015013772A1 Compositions and preparation methods of low melting ionic salts of poorly- water soluble drugs |
| 02/05/2015 | WO2014200872A9 Pharmaceutical compounds targeted by mif affinity-tethered moieties |
| 02/05/2015 | WO2014127475A9 Therapeutic composition for the treatment perianal disorders |
| 02/05/2015 | WO2014071378A9 Substituted indol-5-ol derivatives and their therapeutical applications |
| 02/05/2015 | US20150038851 Meibomian gland dysfunction |
| 02/05/2015 | US20150038719 Agent for Ameliorating Chronic Obstructive Pulmonary Disease |
| 02/05/2015 | US20150038694 Glucose derivatives bound to arsenic for use in the treatment of tumour |
| 02/05/2015 | US20150038690 GELATIN-BASED NANOPARTICLE COMPLEX FOR TUMOR-TARGETED DELIVERY OF siRNA AND METHOD FOR PREPARING THE SAME |
| 02/05/2015 | US20150038686 Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites |
| 02/05/2015 | US20150038589 Nutritional Product Comprising a Biguanide |
| 02/05/2015 | US20150038588 Compositions and methods of treatment of status epilepticus |
| 02/05/2015 | US20150038586 Use of n-acetylcysteine amide in the treatment of penetrating head injury |
| 02/05/2015 | US20150038585 Treatment of Diseases by Concurrently Eliciting Remyelination Effects and Immunomodulatory Effects Using Selective RXR Agonists |
| 02/05/2015 | US20150038583 Orodispersible composition comprising polyunsaturated fatty acids without bad odor or taste |
| 02/05/2015 | US20150038582 Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency |
| 02/05/2015 | US20150038579 Method for Treating Eczema |
| 02/05/2015 | US20150038576 Compositions and their use for smoking cessation and other treatments |
| 02/05/2015 | US20150038572 Administration of a therapeutic amount of genistein to mitigate erectile dysfunction resulting from radiation therapy for prostate cancer only throughout a defined administration period commencing shortly before and concluding after radiation therapy |
| 02/05/2015 | US20150038571 Antiviral Composition against Flavivirus |
| 02/05/2015 | US20150038570 Compositions and products containing s-equol, and methods for their making |
| 02/05/2015 | US20150038569 Anti-cervical Cancer Compound and Method of Use Thereof |
| 02/05/2015 | US20150038568 Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis |
| 02/05/2015 | US20150038565 Long acting compositions |
| 02/05/2015 | US20150038562 Modified L-nucleic Acid |
| 02/05/2015 | US20150038560 Methods and compositions for treating neuropathies |